Molecular mechanisms of protease-mediated tumor invasiveness
- 1 January 1993
- journal article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 53 (S3) , 21-23
- https://doi.org/10.1002/jso.2930530507
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Role of Specific Membrane Receptors in Urokinase-Dependent Migration of Human KeratinocytesJournal of Investigative Dermatology, 1990
- Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.The Journal of cell biology, 1989
- Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.The Journal of cell biology, 1989
- Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells.Molecular and Cellular Biology, 1989
- Urokinase- and Tissue-Type Plasminogen Activators in Keratinocytes During Wound Reepithelialization In VivoJournal of Investigative Dermatology, 1988
- Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitorsThe Journal of cell biology, 1987
- Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascadeCell, 1986
- Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I.Proceedings of the National Academy of Sciences, 1986
- Plasminogen Activators, Tissue Degradation, and CancerPublished by Elsevier ,1985
- Antibodies to plasminogen activator inhibit human tumor metastasisCell, 1983